Cambridge Medical Technologies

Executive Summary

Cambridge Medical Technologies is a UK-based medtech company founded in 2015, operating at the intersection of digital health and diagnostics. The company has developed a proprietary nano-scale fluid sampling and testing platform that enables non-invasive, continuous monitoring of blood analytes through subcutaneous interstitial fluid. This technology delivers real-time, longitudinal biomarker data, with potential applications across multiple medical specialties including diabetes, cardiovascular disease, and chronic kidney disease. By replacing traditional blood draws with a painless, wearable sensor, Cambridge Medical Technologies aims to improve disease management and patient outcomes while reducing healthcare costs. The company is privately held and has not disclosed funding or valuation details. Its technology is still in development, with no commercial products or regulatory approvals announced to date. However, the platform addresses a significant unmet need for continuous, non-invasive monitoring, positioning it as a potential disruptor in the diagnostics market. The company's progress, partnerships, and regulatory milestones will be critical to watch in the coming years.

Upcoming Catalysts (preview)

• Q4 2026Completion of first-in-human clinical study for lead analyte sensor60% success
• H1 2027Strategic partnership with a major pharmaceutical or diagnostics company40% success
• Q2 2027Submission for CE marking under IVDR for the interstitial fluid monitoring system35% success